Search research articles
Contact Us
Filters
Showing results (1081-1090 of 1,421) with videos related to
Page
of 143
Sort By:
Cancer
|
October 1, 1982
Influence of chest radiotherapy in frequency and patterns of chest relapse in disseminated small cell lung carcinoma. A Southwest Oncology Group Study
J G Mira, R B Livingston, T N Moore, et al.
Journal of Neurotrauma
|
February 12, 2008
Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure
Georgene Hergenroeder, John B Redell, Anthony N Moore, et al.
Microbial Ecology
|
March 19, 2013
Oceans and Human Health (OHH): a European perspective from the Marine Board of the European Science Foundation (Marine Board-ESF)
Michael N Moore, Michael H Depledge, Lora Fleming, et al.
Gynecologic Oncology
|
May 11, 2015
A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study
D Scott McMeekin, Michael W Sill, Joan L Walker, et al.
Scientific Reports
|
January 20, 2022
Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer
Sushmita B Gordhandas, Beryl Manning-Geist, Christina Henson, et al.
Investigational New Drugs
|
September 20, 2018
A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors
Antonio Jimeno, Kathleen N Moore, Michael Gordon, et al.
CA: a Cancer Journal for Clinicians
|
January 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.
Journal of the Endocrine Society
|
August 22, 2017
Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290
Elena M Kaftanovskaya, Mariluz Soula, Courtney Myhr, et al.
Environmental Science & Technology
|
March 23, 2021
Tandem Fluorescence Measurements of Organic Matter and Bacteria Released in Sea Spray Aerosols
Mitchell V Santander, Brock A Mitts, Matthew A Pendergraft, et al.
Journal of Hypertension
|
December 1, 2018
Regression to the mean of repeated ambulatory blood pressure monitoring in five studies
Myles N Moore, Emily R Atkins, Abdul Salam, et al.
Page
of 143
Search research articles
Search
Showing results (1081-1090 of 1,421) with videos related to
Sort By:
Page
of 143
Cancer
|
October 1, 1982
Influence of chest radiotherapy in frequency and patterns of chest relapse in disseminated small cell lung carcinoma. A Southwest Oncology Group Study
J G Mira, R B Livingston, T N Moore, et al.
Journal of Neurotrauma
|
February 12, 2008
Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure
Georgene Hergenroeder, John B Redell, Anthony N Moore, et al.
Microbial Ecology
|
March 19, 2013
Oceans and Human Health (OHH): a European perspective from the Marine Board of the European Science Foundation (Marine Board-ESF)
Michael N Moore, Michael H Depledge, Lora Fleming, et al.
Gynecologic Oncology
|
May 11, 2015
A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study
D Scott McMeekin, Michael W Sill, Joan L Walker, et al.
Scientific Reports
|
January 20, 2022
Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer
Sushmita B Gordhandas, Beryl Manning-Geist, Christina Henson, et al.
Investigational New Drugs
|
September 20, 2018
A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors
Antonio Jimeno, Kathleen N Moore, Michael Gordon, et al.
CA: a Cancer Journal for Clinicians
|
January 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.
Journal of the Endocrine Society
|
August 22, 2017
Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290
Elena M Kaftanovskaya, Mariluz Soula, Courtney Myhr, et al.
Environmental Science & Technology
|
March 23, 2021
Tandem Fluorescence Measurements of Organic Matter and Bacteria Released in Sea Spray Aerosols
Mitchell V Santander, Brock A Mitts, Matthew A Pendergraft, et al.
Journal of Hypertension
|
December 1, 2018
Regression to the mean of repeated ambulatory blood pressure monitoring in five studies
Myles N Moore, Emily R Atkins, Abdul Salam, et al.
Page
of 143